These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 9412705)
1. Immunological markers in HIV-infected pregnant women. The European Collaborative Study and the Swiss HIV Pregnancy Cohort. AIDS; 1997 Dec; 11(15):1859-65. PubMed ID: 9412705 [TBL] [Abstract][Full Text] [Related]
2. HIV infection in women: immunological markers and the influence of pregnancy. Brettle RP; Raab GM; Ross A; Fielding KL; Gore SM; Bird AG AIDS; 1995 Oct; 9(10):1177-84. PubMed ID: 8519455 [TBL] [Abstract][Full Text] [Related]
3. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II. AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 and immunological changes during pregnancy: a comparison between HIV-1-seropositive and HIV-1-seronegative women in Nairobi, Kenya. Temmerman M; Nagelkerke N; Bwayo J; Chomba EN; Ndinya-Achola J; Piot P AIDS; 1995 Sep; 9(9):1057-60. PubMed ID: 8527078 [TBL] [Abstract][Full Text] [Related]
5. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers. Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977 [TBL] [Abstract][Full Text] [Related]
6. HIV-infected pregnant women and vertical transmission in Europe since 1986. European collaborative study. AIDS; 2001 Apr; 15(6):761-70. PubMed ID: 11371691 [TBL] [Abstract][Full Text] [Related]
7. Serum ferritin levels in normal and HIV-1 infected pregnant women. Phuapradit W; Taeepanichskul S; Jetsawangsri T; Chaturachinda K; Khupulsup K; Kunakorn M Aust N Z J Obstet Gynaecol; 1996 Feb; 36(1):24-6. PubMed ID: 8775245 [TBL] [Abstract][Full Text] [Related]
8. Viral studies of mothers with human immunodeficiency virus infection at delivery and their infants in the first 3 days of life. Sison AV; Brandt CD; Rakusan TA; Wientzen R; Fuccillo DA; Sever JL Pediatr AIDS HIV Infect; 1996 Oct; 7(5):325-30. PubMed ID: 11361490 [TBL] [Abstract][Full Text] [Related]
9. HIV antibody responses in children of HIV-infected mothers. Sever JL; Rakusan TA; Campos JM; O'Donnell RM; Price VA Pediatr AIDS HIV Infect; 1996 Aug; 7(4):246-53. PubMed ID: 11361717 [TBL] [Abstract][Full Text] [Related]
10. Predictors and reference values of CD4 and CD8 T lymphocyte counts in pregnancy: a cross sectional study among HIV negative women in Zimbabwe. Gomo E; Vennervald BJ; Ndhlovu P; Kaestel P; Nyazema N; Friis H Cent Afr J Med; 2004; 50(1-2):10-9. PubMed ID: 15490719 [TBL] [Abstract][Full Text] [Related]
11. HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy. Tamburrini E; Ravizza M; Floridia M; Tibaldi C; Alberico S; Anzidei G; Maccabruni A; Meloni A; Antoni AD; Mori F; Dalzero S; Conservan V; Pinnetti C; Ferrazzi E; Antivir Ther; 2008; 13(4):519-27. PubMed ID: 18672530 [TBL] [Abstract][Full Text] [Related]
12. Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of < or = 500/microL. Watts DH; Lambert JS; Stiehm ER; Bethel J; Whitehouse J; Fowler MG; Read J Am J Obstet Gynecol; 2000 Jul; 183(1):100-7. PubMed ID: 10920316 [TBL] [Abstract][Full Text] [Related]
13. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis. Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172 [TBL] [Abstract][Full Text] [Related]
14. 162 HIV-1 infected pregnant women and vertical transmission. Results of a prospective study. Ferrero S; Gotta G; Melica G; Biasotti B; Ravera G; Bentivoglio G Minerva Ginecol; 2002 Oct; 54(5):373-85. PubMed ID: 12364883 [TBL] [Abstract][Full Text] [Related]
15. The relationship of pregnancy to the use of highly active antiretroviral therapy. Minkoff H; Ahdieh L; Watts H; Greenblatt RM; Schmidt J; Schneider M; Stek A Am J Obstet Gynecol; 2001 May; 184(6):1221-7. PubMed ID: 11349192 [TBL] [Abstract][Full Text] [Related]
16. Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission Study. Navas-Nacher EL; Read JS; Leighty RM; Tuomala RE; Zorrilla CD; Landesman S; Rosenblatt H; Hershow RC; AIDS; 2006 Feb; 20(3):429-36. PubMed ID: 16439877 [TBL] [Abstract][Full Text] [Related]
17. [HIV and pregnancy]. Rudin C; Camli C; Schnüriger H; Biedermann K; Lauper U; Kind C Schweiz Med Wochenschr; 1995 Dec; 125(48):2322-9. PubMed ID: 8539580 [TBL] [Abstract][Full Text] [Related]
18. Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women. Wright PF; Lambert JS; Gorse GJ; Hsieh RH; McElrath MJ; Weinhold K; Wara DW; Anderson EL; Keefer MC; Jackson S; Wagner LJ; Francis DP; Fast PE; McNamara J J Infect Dis; 1999 Oct; 180(4):1080-8. PubMed ID: 10479134 [TBL] [Abstract][Full Text] [Related]
19. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model. Hendriks JC; Craib KJ; Veugelers PJ; van Druten HA; Coutinho RA; Schechter MT; van Griensven GJ Int J Epidemiol; 2000 Jun; 29(3):565-72. PubMed ID: 10869332 [TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen. Azria E; Moutafoff C; Schmitz T; Le Meaux JP; Krivine A; Pannier E; Firtion G; Compagnucci A; Finkielsztejn L; Taulera O; Tsatsaris V; Cabrol D; Launay O Antivir Ther; 2009; 14(3):423-32. PubMed ID: 19474476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]